1. Home
  2. ORIQ vs ORMP Comparison

ORIQ vs ORMP Comparison

Compare ORIQ & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORIQ
  • ORMP
  • Stock Information
  • Founded
  • ORIQ 2024
  • ORMP 2002
  • Country
  • ORIQ Singapore
  • ORMP United States
  • Employees
  • ORIQ N/A
  • ORMP N/A
  • Industry
  • ORIQ
  • ORMP Biotechnology: Pharmaceutical Preparations
  • Sector
  • ORIQ
  • ORMP Health Care
  • Exchange
  • ORIQ Nasdaq
  • ORMP Nasdaq
  • Market Cap
  • ORIQ 87.2M
  • ORMP 104.6M
  • IPO Year
  • ORIQ 2025
  • ORMP N/A
  • Fundamental
  • Price
  • ORIQ $10.10
  • ORMP $2.36
  • Analyst Decision
  • ORIQ
  • ORMP
  • Analyst Count
  • ORIQ 0
  • ORMP 0
  • Target Price
  • ORIQ N/A
  • ORMP N/A
  • AVG Volume (30 Days)
  • ORIQ 23.4K
  • ORMP 116.9K
  • Earning Date
  • ORIQ 01-01-0001
  • ORMP 11-07-2025
  • Dividend Yield
  • ORIQ N/A
  • ORMP N/A
  • EPS Growth
  • ORIQ N/A
  • ORMP N/A
  • EPS
  • ORIQ N/A
  • ORMP N/A
  • Revenue
  • ORIQ N/A
  • ORMP $2,000,000.00
  • Revenue This Year
  • ORIQ N/A
  • ORMP N/A
  • Revenue Next Year
  • ORIQ N/A
  • ORMP N/A
  • P/E Ratio
  • ORIQ N/A
  • ORMP N/A
  • Revenue Growth
  • ORIQ N/A
  • ORMP N/A
  • 52 Week Low
  • ORIQ $9.98
  • ORMP $1.82
  • 52 Week High
  • ORIQ $10.12
  • ORMP $3.09
  • Technical
  • Relative Strength Index (RSI)
  • ORIQ N/A
  • ORMP 50.60
  • Support Level
  • ORIQ N/A
  • ORMP $2.31
  • Resistance Level
  • ORIQ N/A
  • ORMP $2.45
  • Average True Range (ATR)
  • ORIQ 0.00
  • ORMP 0.11
  • MACD
  • ORIQ 0.00
  • ORMP -0.00
  • Stochastic Oscillator
  • ORIQ 0.00
  • ORMP 60.76

About ORIQ Origin Investment Corp I Ordinary Shares

Origin Investment Corp I is a blank check company.

About ORMP Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.

Share on Social Networks: